Patented Medicine Prices Review Board
http://dbpedia.org/resource/Patented_Medicine_Prices_Review_Board an entity of type: Thing
The Patented Medicine Prices Review Board (French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the Canadian pharmaceutical industry.
rdf:langString
rdf:langString
Patented Medicine Prices Review Board
rdf:langString
Patented Medicine Prices Review Board
xsd:integer
17830047
xsd:integer
1055140932
rdf:langString
CA$10.3 million
xsd:integer
74
rdf:langString
PMPRB logo.svg
rdf:langString
rdf:langString
The Patented Medicine Prices Review Board (French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the Canadian pharmaceutical industry. The board investigates, reviews and negotiates the price of individual drugs that are still under patent and which have no generic substitutes. It establishes the maximum prices that can be charged in Canada for patented drugs.
rdf:langString
Mitchell Levine
rdf:langString
Chairperson
rdf:langString
Mélanie Bourassa Forcier
rdf:langString
Vice-chairperson
rdf:langString
Douglas Clark
rdf:langString
Executive Director
rdf:langString
Patent Act
xsd:nonNegativeInteger
7124
<usDollar>
1.03E7
xsd:gYear
1987
xsd:nonNegativeInteger
74